Resources library
Welcome to our resource library. We invite you to explore and view our extensive resources and information.
OXB Global Brochure 2026
This brochure highlights OXB's capabilities, showcasing our platforms, technical expertise, and client-centric ways of working across the cell and gene therapy journey.
View Resource >
Vectors Without Borders: Building a Global Viral Vector CDMO
An inside look at OXB’s transformation into a global viral vector CDMO, including the expansion of its manufacturing network, faster delivery timelines and growing support for late-stage and commercial programmes. Based on an interview of OXB's Chief Business Officer, Sebastien Ribault and published in Manufacturing Today.
View details >
OXB Flash Talks: The Strategic Side of Regulatory Development
This episode examines how regulatory strategy, from early agency engagement to global submissions, can help de-risk and accelerate cell and gene therapy development.
View details >
PPQ Readiness Guide
Preparing for PPQ? Explore six essential questions to help assess readiness, reduce risk and prepare your programme for commercial manufacturing.
View details >
In vivo CAR‑T – Reimagining Immune Engineering with Direct Cell Reprogramming
An overview of the opportunities and challenges of in vivo CAR-T therapy, including the technologies that could transform how next-generation cell therapies are delivered to patients. Published in The Medicine Maker.
View details >Isolating T-Cell Potent Lentiviral Vector Subpopulations through Rational Design of Nanofiber Anion-Exchange Adsorbents
This paper investigates lentiviral vector heterogeneity during anion-exchange chromatography and identifies a nanofiber-based purification approach that enhances recovery and separation of high-potency vectors.
View details >
Late-Stage Capabilities One Pager
Learn how OXB supports the transition from late-stage development to commercial supply through proven expertise in process characterisation, PPQ, regulatory submissions and commercial-scale GMP manufacturing.
View details >